• New
  • Out-of-Stock
Rx: TGP Sitagliptin 50mg FCTablet
search
  • Rx: TGP Sitagliptin 50mg FCTablet
  • Rx: TGP Sitagliptin 50mg FCTablet
  • Rx: TGP Sitagliptin 50mg FCTablet
  • Rx: TGP Sitagliptin 50mg FCTablet

Rx: TGP Sitagliptin 50mg FCTablet

TGP
Out of Stock

Rx: TGP Sitagliptin 50mg FCTab refers to a prescription medication that contains Sitagliptin as its active ingredient. Sitagliptin is used in the management of type 2 diabetes mellitus. The medication is available in the form of film-coated tablets, each containing 50 mg of Sitagliptin.

₱20.00
Out of Stock
Quantity
Sold Out

favorite Add to wishlist

You must be logged
4806526159422

Description:

1. Formulation
The typical formulation of Sitagliptin 50mg film-coated tablets includes:
o Active Ingredient: Sitagliptin Phosphate Monohydrate, which is the drug responsible for the therapeutic effects.
o Excipients: These are inactive ingredients that help in the manufacturing of the tablet and may include:

I. Binders: Such as hypromellose, which helps in binding the tablet components together.
II. Fillers: Such as microcrystalline cellulose, which adds bulk to the tablet.
III. Coating Agents: Like hydroxypropyl methylcellulose and titanium dioxide, which form the film coating.
IV. Stabilizers: Such as magnesium stearate, which helps in maintaining the tablet's stability.
V. Colorants: Used to give the tablet its color, though specific colorants vary by manufacturer.

2. Indications
Sitagliptin is indicated for:
o Type 2 Diabetes Mellitus: Sitagliptin is used to improve glycemic control in adults with type 2 diabetes. It is typically prescribed when diet and exercise alone are not sufficient to achieve desired blood glucose levels.
o In Combination Therapy: It can be used alone or in combination with other antidiabetic medications, such as metformin or a sulfonylurea, to enhance blood glucose control.

3. Contraindications
Sitagliptin has several contraindications and precautions:
o Hypersensitivity: Should not be used in patients with a known hypersensitivity to Sitagliptin or any of the other tablet components.
o Type 1 Diabetes or Diabetic Ketoacidosis: It is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis.
o Severe Renal Impairment: Use with caution or avoid use in patients with severe renal impairment or end-stage renal disease without appropriate dose adjustment.
o History of Pancreatitis: Patients with a history of pancreatitis should use Sitagliptin with caution, as it may be associated with an increased risk of pancreatitis.
o Pregnancy and Lactation: Safety in pregnancy and lactation has not been established, so it should be used only if clearly needed and prescribed by a healthcare provider.

TGP
4806526159422

Customers who bought this product also bought: